These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 9543391

  • 1. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases.
    Kubota Y, Angelotti T, Niederfellner G, Herbst R, Ullrich A.
    Cell Growth Differ; 1998 Mar; 9(3):247-56. PubMed ID: 9543391
    [Abstract] [Full Text] [Related]

  • 2. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F, Gao G, Wang LM, Landstrom TR, Degerman E, Pierce JH, Manganiello VC.
    J Immunol; 1999 Apr 15; 162(8):4864-75. PubMed ID: 10202031
    [Abstract] [Full Text] [Related]

  • 3. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 15; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 4. Uncoupling of the proliferation and differentiation signals mediated by the murine macrophage colony-stimulating factor receptor expressed in myeloid FDC-P1 cells.
    Bourette RP, Myles GM, Carlberg K, Chen AR, Rohrschneider LR.
    Cell Growth Differ; 1995 Jun 15; 6(6):631-45. PubMed ID: 7545432
    [Abstract] [Full Text] [Related]

  • 5. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 Jun 15; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 6. Responses of the murine myeloid cell line FDC-P1 to soluble and membrane-bound forms of steel factor (SLF).
    Caruana G, Ashman LK, Fujita J, Gonda TJ.
    Exp Hematol; 1993 Jun 15; 21(6):761-8. PubMed ID: 7684700
    [Abstract] [Full Text] [Related]

  • 7. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
    Rossner MT, McArthur GA, Allen JD, Metcalf D.
    Cell Growth Differ; 1994 May 15; 5(5):549-55. PubMed ID: 8049161
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
    Qi JH, Claesson-Welsh L.
    Exp Cell Res; 2001 Feb 01; 263(1):173-82. PubMed ID: 11161716
    [Abstract] [Full Text] [Related]

  • 11. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
    Shivakrupa R, Bernstein A, Watring N, Linnekin D.
    Cancer Res; 2003 Aug 01; 63(15):4412-9. PubMed ID: 12907613
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the mitogenic pathway of the FLT3 receptor and characterization in its C terminal region of a specific binding site for the PI3' kinase.
    Casteran N, Rottapel R, Beslu N, Lecocq E, Birnbaum D, Dubreuil P.
    Cell Mol Biol (Noisy-le-grand); 1994 May 01; 40(3):443-56. PubMed ID: 7920189
    [Abstract] [Full Text] [Related]

  • 13. The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner.
    Ekman N, Arighi E, Rajantie I, Saharinen P, Ristimäki A, Silvennoinen O, Alitalo K.
    Oncogene; 2000 Aug 24; 19(36):4151-8. PubMed ID: 10962576
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM.
    Oncogene; 2000 Aug 17; 19(35):3999-4010. PubMed ID: 10962556
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of pp60c-src kinase activity in FDC-P1 cells by polyoma middle-T antigen and hematopoietic growth factors.
    Muser J, Kaech S, Moroni C, Ballmer-Hofer K.
    Oncogene; 1989 Dec 17; 4(12):1433-9. PubMed ID: 2480561
    [Abstract] [Full Text] [Related]

  • 16. Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1.
    Ashman LK, Bühring HJ, Aylett GW, Broudy VC, Müller C.
    J Cell Physiol; 1994 Mar 17; 158(3):545-54. PubMed ID: 7510297
    [Abstract] [Full Text] [Related]

  • 17. Hematopoietic growth factor receptors.
    Brizzi MF, Avanzi GC, Pegoraro L.
    Int J Cell Cloning; 1991 Jul 17; 9(4):274-300. PubMed ID: 1894957
    [Abstract] [Full Text] [Related]

  • 18. The cytokine receptor repertoire specifies autocrine growth factor production in factor-dependent cells.
    Rasko JE, Metcalf D, Gough NM, Begley CG.
    Exp Hematol; 1995 May 17; 23(5):453-60. PubMed ID: 7720817
    [Abstract] [Full Text] [Related]

  • 19. Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factors.
    Merlo GR, Graus-Porta D, Cella N, Marte BM, Taverna D, Hynes NE.
    Eur J Cell Biol; 1996 Jun 17; 70(2):97-105. PubMed ID: 8793381
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.
    Buchdunger E, Zimmermann J, Mett H, Meyer T, Müller M, Druker BJ, Lydon NB.
    Cancer Res; 1996 Jan 01; 56(1):100-4. PubMed ID: 8548747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.